246 related articles for article (PubMed ID: 31197942)
1. Furowanin A Exhibits Antiproliferative and Pro-Apoptotic Activities by Targeting Sphingosine Kinase 1 in Osteosarcoma.
Wei K; Sun H; Chen X; Chen Q; Li Y; Wu H
Anat Rec (Hoboken); 2019 Nov; 302(11):1941-1949. PubMed ID: 31197942
[TBL] [Abstract][Full Text] [Related]
2. Soyasapogenol B exhibits anti-growth and anti-metastatic activities in clear cell renal cell carcinoma.
Wang L; Wang J; Zhao H; Jiang G; Feng X; Sui W; Liu H
Naunyn Schmiedebergs Arch Pharmacol; 2019 May; 392(5):551-563. PubMed ID: 30607469
[TBL] [Abstract][Full Text] [Related]
3. Identification of profilin 1 as the primary target for the anti-cancer activities of Furowanin A in colorectal cancer.
Zhao J; Xu J; Lv J
Pharmacol Rep; 2019 Oct; 71(5):940-949. PubMed ID: 31454697
[TBL] [Abstract][Full Text] [Related]
4. Co-administration phenoxodiol with doxorubicin synergistically inhibit the activity of sphingosine kinase-1 (SphK1), a potential oncogene of osteosarcoma, to suppress osteosarcoma cell growth both in vivo and in vitro.
Yao C; Wu S; Li D; Ding H; Wang Z; Yang Y; Yan S; Gu Z
Mol Oncol; 2012 Aug; 6(4):392-404. PubMed ID: 22583777
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine kinase 1 contributes to doxorubicin resistance and glycolysis in osteosarcoma.
Ren X; Su C
Mol Med Rep; 2020 Sep; 22(3):2183-2190. PubMed ID: 32705189
[TBL] [Abstract][Full Text] [Related]
6. Furowanin A-induced autophagy alleviates apoptosis and promotes cell cycle arrest via inactivation STAT3/Mcl-1 axis in colorectal cancer.
Ma Z; Bao X; Gu J
Life Sci; 2019 Feb; 218():47-57. PubMed ID: 30562490
[TBL] [Abstract][Full Text] [Related]
7. Euxanthone Impairs the Metastatic Potential of Osteosarcoma by Reducing COX-2 Expression.
Chen X; Deng M; Zhou X; Wang X; Ye Y; Zhu J; Jiang H; Chen X; Zha W
Anat Rec (Hoboken); 2019 Aug; 302(8):1399-1408. PubMed ID: 30334373
[TBL] [Abstract][Full Text] [Related]
8. Identification of sphingosine kinase 1 (SphK1) as a primary target of icaritin in hepatocellular carcinoma cells.
Lu PH; Chen MB; Liu YY; Wu MH; Li WT; Wei MX; Liu CY; Qin SK
Oncotarget; 2017 Apr; 8(14):22800-22810. PubMed ID: 28206952
[TBL] [Abstract][Full Text] [Related]
9. S1P/S1PR3 axis promotes aerobic glycolysis by YAP/c-MYC/PGAM1 axis in osteosarcoma.
Shen Y; Zhao S; Wang S; Pan X; Zhang Y; Xu J; Jiang Y; Li H; Zhang Q; Gao J; Yang Q; Zhou Y; Jiang S; Yang H; Zhang Z; Zhang R; Li J; Zhou D
EBioMedicine; 2019 Feb; 40():210-223. PubMed ID: 30587459
[TBL] [Abstract][Full Text] [Related]
10. The therapeutic value of the SphK1-targeting microRNA-3677 in human osteosarcoma cells.
Yao C; Ruan JW; Zhu YR; Liu F; Wu HM; Zhang Y; Jiang Q
Aging (Albany NY); 2020 Mar; 12(6):5399-5410. PubMed ID: 32203055
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation and tumor-promoting role of SPHK1 were attenuated by miR-330-3p in gastric cancer.
Wang Z; Qu H; Gong W; Liu A
IUBMB Life; 2018 Nov; 70(11):1164-1176. PubMed ID: 30281914
[TBL] [Abstract][Full Text] [Related]
12. PLK2 modulation of enriched TAp73 affects osteogenic differentiation and prognosis in human osteosarcoma.
Li W; Zhang X; Xi X; Li Y; Quan H; Liu S; Wu L; Wu P; Lan W; Shao Y; Li H; Chen K; Hu Z
Cancer Med; 2020 Jun; 9(12):4371-4385. PubMed ID: 32349184
[TBL] [Abstract][Full Text] [Related]
13. Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma.
Nomura M; Rainusso N; Lee YC; Dawson B; Coarfa C; Han R; Larson JL; Shuck R; Kurenbekova L; Yustein JT
J Natl Cancer Inst; 2019 Nov; 111(11):1216-1227. PubMed ID: 30793158
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p.
Yang C; Wu K; Wang S; Wei G
J Cell Biochem; 2018 Jul; 119(7):5646-5656. PubMed ID: 29384226
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-661 Enhances TRAIL or STS Induced Osteosarcoma Cell Apoptosis by Modulating the Expression of Cytochrome c1.
Fan L; Zhu C; Qiu R; Zan P; Zheng Z; Xu T; Li G
Cell Physiol Biochem; 2017; 41(5):1935-1946. PubMed ID: 28391262
[TBL] [Abstract][Full Text] [Related]
16. Apigenin induces apoptosis through mitochondrial dysfunction in U-2 OS human osteosarcoma cells and inhibits osteosarcoma xenograft tumor growth in vivo.
Lin CC; Chuang YJ; Yu CC; Yang JS; Lu CC; Chiang JH; Lin JP; Tang NY; Huang AC; Chung JG
J Agric Food Chem; 2012 Nov; 60(45):11395-402. PubMed ID: 23066961
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-506-3p initiates mesenchymal-to-epithelial transition and suppresses autophagy in osteosarcoma cells by directly targeting SPHK1.
Wang D; Bao F; Teng Y; Li Q; Li J
Biosci Biotechnol Biochem; 2019 May; 83(5):836-844. PubMed ID: 30669957
[TBL] [Abstract][Full Text] [Related]
18. Gelsolin promotes cell growth and invasion through the upregulation of p-AKT and p-P38 pathway in osteosarcoma.
Ma X; Sun W; Shen J; Hua Y; Yin F; Sun M; Cai Z
Tumour Biol; 2016 Jun; 37(6):7165-74. PubMed ID: 26662962
[TBL] [Abstract][Full Text] [Related]
19. Secreted clusterin (sCLU) regulates cell proliferation and chemosensitivity to cisplatin by modulating ERK1/2 signals in human osteosarcoma cells.
Huang H; Wang L; Li M; Wang X; Zhang L
World J Surg Oncol; 2014 Aug; 12():255. PubMed ID: 25106434
[TBL] [Abstract][Full Text] [Related]
20. Hispidulin mediates apoptosis in human renal cell carcinoma by inducing ceramide accumulation.
Gao H; Gao MQ; Peng JJ; Han M; Liu KL; Han YT
Acta Pharmacol Sin; 2017 Dec; 38(12):1618-1631. PubMed ID: 29119970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
